Literature DB >> 17386317

Collagenofibrotic glomerulopathy: clinicopathologic overview of a rare glomerular disease.

Bassam Alchi1, Shinichi Nishi, Ichiei Narita, Fumitake Gejyo.   

Abstract

Collagenofibrotic glomerulopathy is an idiopathic glomerular disease characterized by massive accumulation of atypical type III collagen fibrils within the mesangial matrix and subendothelial space and marked increase in serum type III procollagen peptide levels. The disease is extremely rare, with most cases reported in Japan. The cause and pathogenesis are entirely elusive. Some cases were described in families; hence, a genetic mode of transmission, mostly by an autosomal recessive trait, has been assumed. Controversy exists about whether the glomerulopathy is a primary renal disease or manifestation of systemic disease. Proteinuria is a cardinal manifestation of this disease. Clinically, patients present with edema and hypertension and often progress to end-stage renal disease. A definite diagnosis can be established when typical histological findings are supported by immunohistochemistry for specific collagen types and electron microscopy with special staining methods. No specific treatment is available.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17386317     DOI: 10.1053/j.ajkd.2007.01.020

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  14 in total

Review 1.  Differential diagnosis of glomerular disease: a systematic and inclusive approach.

Authors:  Lee A Hebert; Samir Parikh; Jason Prosek; Tibor Nadasdy; Brad H Rovin
Journal:  Am J Nephrol       Date:  2013-09-13       Impact factor: 3.754

2.  Two brothers with collagenofibrotic glomerulopathy.

Authors:  Takafumi Aoki; Kazuyuki Hayashi; Takatoshi Morinaga; Hidetaka Tomida; Manabu Hishida; Satoko Yamamoto; Nobuyuki Kajiwara; Hirofumi Tamai
Journal:  CEN Case Rep       Date:  2014-09-18

3.  Glomerulopathy with distinctive fibrillar deposits but lacking glomerular deposition of type III collagen.

Authors:  Tatsuo Yamamoto; Akashi Togawa; Masanobu Eguchi; Naro Ohashi; Hideo Yasuda; Yutaka Harita; Motoshi Hattori; Yutaka Yamaguchi; Kunio Ohyama
Journal:  CEN Case Rep       Date:  2016-03-08

4.  Collagen type III glomerulopathy: A case report and review of 20 cases.

Authors:  Junwu Dong; Honglan Wei; Min Han; Yang Guan; Yang Wu; Hua Li
Journal:  Exp Ther Med       Date:  2015-08-20       Impact factor: 2.447

5.  Deficiency of liver sinusoidal scavenger receptors stabilin-1 and -2 in mice causes glomerulofibrotic nephropathy via impaired hepatic clearance of noxious blood factors.

Authors:  Kai Schledzewski; Cyrill Géraud; Bernd Arnold; Shijun Wang; Hermann-Josef Gröne; Tibor Kempf; Kai C Wollert; Beate K Straub; Peter Schirmacher; Alexandra Demory; Hiltrud Schönhaber; Alexei Gratchev; Lisa Dietz; Hermann-Josef Thierse; Julia Kzhyshkowska; Sergij Goerdt
Journal:  J Clin Invest       Date:  2011-02       Impact factor: 14.808

Review 6.  The renal biopsy in the genomic era.

Authors:  Helen Liapis; Joseph P Gaut
Journal:  Pediatr Nephrol       Date:  2012-11-21       Impact factor: 3.714

7.  Collagenofibrotic glomerulopathy - Case report with review of literature.

Authors:  K C Patro; R Jha; M Sahay; G Swarnalatha
Journal:  Indian J Nephrol       Date:  2011-01

8.  When the finding of glomerular fibrils in patients with nephrotic syndrome leads to an erroneous diagnosis.

Authors:  Ana Huerta; Beatriz Segovia; Aurelio Hernández; Enrique Morales; Jorge González; Eva Mérida; Miguel Angel Martínez; Manuel Praga
Journal:  NDT Plus       Date:  2008-11-12

9.  Collagenofibrotic glomerulopathy: three case reports in Brazil.

Authors:  Renata D R Ferreira; Fabiano B Custódio; Camila S O Guimarães; Rosana R M Corrêa; Marlene A Reis
Journal:  Diagn Pathol       Date:  2009-09-25       Impact factor: 2.644

10.  Diagnosis of Collagen Type III Glomerulopathy Using Picrosirius Red and PASH/Masson's Trichrome Stain.

Authors:  Katelin L Davis; Anne L Burnum; Jessica A Beck; Shannon G M Kirejczyk; Margaret A Miller; Mario F Sola; Cathy A Brown
Journal:  Vet Pathol       Date:  2020-06-17       Impact factor: 2.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.